Angioedema, Angiotensin Converting Enzyme Inhibitors, and Angiotensin Receptor Blocking Drugs

Canadian Journal of Anaesthesia - United States
doi 10.1007/bf03022016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin Receptor Blockers

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System
Internal MedicineEndocrinology
2006English

Angiotensin-Converting Enzyme Inhibitors and Angioedema: Estimating the Risk

Hypertension
Internal Medicine
2008English

Combining Angiotensin-Receptor Blockers With Angiotensin-Converting-Enzyme Inhibitors

CMAJ
Medicine
2011English

Angiotensin Converting Enzyme (ACE) Inhibitors

Annual Review of Pharmacology and Toxicology
ToxicologyPharmacology
1982English

Comparison of Angiotensin Receptor Blockers and Angiotensin Converting Enzyme Inhibitors for Glycaemic Regulation

Endocrine Abstracts
2014English

Angiotensin-Converting Enzyme and Dipeptidyl Peptidase IV Inhibitors: An Increased Risk of Angioedema

Hypertension
Internal Medicine
2009English

Angiotensin-Converting Enzyme Inhibitors (ACE-Is) Versus Angiotensin- Receptor Blockers (ARBs): Any Superiority?

Journal of Hypertension- Open Access
2012English

Dosage of Angiotensin Converting Enzyme Inhibitors

BMJ
1995English

Angiotensin Converting Enzyme Inhibitors and Diabetic Nephropathy.

BMJ
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy